MSB 2.55% $1.01 mesoblast limited

Ann: MSB Reports Q3 Financial Results and Operational Highlights, page-327

  1. 5,115 Posts.
    lightbulb Created with Sketch. 411
    Not having your expertise, I sense you are on point.

    Covid has exposed corruption between the FDA and big pharma for what it is. I believe that stem cells and AI are the big movers in the next decade. This is an opportunity for the FDA to get leg up of big pharma and provide them with ultimate leverage. As such i suspect approval in August a slam dunk.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.01
Change
0.025(2.55%)
Mkt cap ! $1.153B
Open High Low Value Volume
99.5¢ $1.02 99.0¢ $3.029M 3.018M

Buyers (Bids)

No. Vol. Price($)
104 208506 $1.00
 

Sellers (Offers)

Price($) Vol. No.
$1.01 71938 21
View Market Depth
Last trade - 13.35pm 28/06/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.